The endocannabinoid system and NGF are involved in the mechanism of action of resveratrol: a multi-target nutraceutical with therapeutic potential in neuropsychiatric disorders (Q47595268)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	The endocannabinoid system and NGF are involved in the mechanism of action of resveratrol: a multi-target nutraceutical with therapeutic potential in neuropsychiatric disorders	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/26780936

The endocannabinoid system and NGF are involved in the mechanism of action of resveratrol: a multi-target nutraceutical with therapeutic potential in neuropsychiatric disorders (English)

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/26780936

endocannabinoid system

0 references

1 reference

based on heuristic

inferred from title

3

object named as

Fatemeh Atyabi

1 reference

Europe PubMed Central

4 February 2018

author name string

Parichehr Hassanzadeh

1

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/26780936

Elham Arbabi

2

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/26780936

Rassoul Dinarvand

4

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/26780936

publication date

18 January 2016

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/26780936

Psychopharmacology

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/26780936

233

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/26780936

6

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/26780936

1087-1096

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/26780936

https://scigraph.springernature.com/pub.10.1007/s00213-015-4188-3

0 references

The cannabinoid antagonist SR144528 enhances the acute effect of WIN 55,212-2 on gastrointestinal motility in the rat.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4188-3

21 January 2018

Nerve Growth Factor: A Focus on Neuroscience and Therapy

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4188-3

21 January 2018

Endocannabinoids in the treatment of mood disorders: evidence from animal models

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4188-3

21 January 2018

Chronic unpredictable stress decreases cell proliferation in the cerebral cortex of the adult rat.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4188-3

21 January 2018

Prevalence of mental disorders based on general population surveys

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4188-3

21 January 2018

New approaches to antidepressant drug discovery: beyond monoamines

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4188-3

21 January 2018

Clonazepam-induced intestinal motor disturbances are linked to central nervous system release of cholecystokinin in rats.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4188-3

21 January 2018

Protective effects of resveratrol and quercetin against MPP+ -induced oxidative stress act by modulating markers of apoptotic death in dopaminergic neurons.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4188-3

21 January 2018

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4188-3

21 January 2018

Resveratrol and quercetin, two natural polyphenols, reduce apoptotic neuronal cell death induced by neuroinflammation

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4188-3

21 January 2018

Role of neurotrophic factors in depression

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4188-3

21 January 2018

Amitriptyline-mediated cognitive enhancement in aged 3×Tg Alzheimer's disease mice is associated with neurogenesis and neurotrophic activity

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4188-3

21 January 2018

Combination therapy with intranasal NGF and electroacupuncture enhanced cell proliferation and survival in rats after stroke

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4188-3

21 January 2018

NGF is essential for hippocampal plasticity and learning

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4188-3

21 January 2018

Effect of repeated systemic administration of selective inhibitors of endocannabinoid inactivation on rat brain endocannabinoid levels

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4188-3

21 January 2018

The cannabinoid receptor CB₁ inverse agonist AM251 potentiates the anxiogenic activity of urocortin I in the basolateral amygdala.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4188-3

21 January 2018

The novel trisubstituted pyran derivative D-142 has triple monoamine reuptake inhibitory activity and exerts potent antidepressant-like activity in rodents.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4188-3

21 January 2018

Function and evolution in the NGF family and its receptors

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4188-3

21 January 2018

Beneficial effects of resveratrol on atherosclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4188-3

21 January 2018

CB1 receptor blockade decreases ethanol intake and associated neurochemical changes in fawn-hooded rats

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4188-3

21 January 2018

Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4188-3

21 January 2018

Time-dependent increase in basic fibroblast growth factor protein in limbic regions following electroshock seizures.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4188-3

21 January 2018

Neuroprotective effects of resveratrol against beta-amyloid-induced neurotoxicity in rat hippocampal neurons: involvement of protein kinase C

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4188-3

21 January 2018

The cannabinergic system is implicated in the upregulation of central NGF protein by psychotropic drugs.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4188-3

21 January 2018

Involvement of the neurotrophin and cannabinoid systems in the mechanisms of action of neurokinin receptor antagonists.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4188-3

21 January 2018

The CB₁ receptor-mediated endocannabinoid signaling and NGF: the novel targets of curcumin.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4188-3

21 January 2018

Implication of NGF and endocannabinoid signaling in the mechanism of action of sesamol: a multi-target natural compound with therapeutic potential

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4188-3

21 January 2018

Serotonergic lesion of median raphe nucleus alters nerve growth factor content and vulnerability of cholinergic septohippocampal neurons in rat.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4188-3

21 January 2018

Subchronic treatment with lithium increases nerve growth factor content in distinct brain regions of adult rats.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4188-3

21 January 2018

Neurotrophins: roles in neuronal development and function

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4188-3

21 January 2018

Antidepressant effects of resveratrol in an animal model of depression

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4188-3

21 January 2018

Amitriptyline is a TrkA and TrkB receptor agonist that promotes TrkA/TrkB heterodimerization and has potent neurotrophic activity

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4188-3

21 January 2018

Involvement of brain-derived neurotrophic factor in cannabinoid receptor-dependent protection against excitotoxicity

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4188-3

21 January 2018

Nerve Growth Factor: Structure, Function and Therapeutic Implications for Alzheimers Disease

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4188-3

21 January 2018

Cannabinoids and emotionality: a neuroanatomical perspective.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4188-3

21 January 2018

Serum resistin increases in a postprandial state during liquid meal challenge test in healthy human subjects.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4188-3

21 January 2018

The effects of resveratrol, a phytoalexin derived from red wines, on chronic inflammation induced in an experimentally induced colitis model

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4188-3

21 January 2018

Role of nerve growth factor in the olfactory system

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4188-3

21 January 2018

The burden of severe depression: a review of diagnostic challenges and treatment alternatives

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4188-3

21 January 2018

The endocannabinoid system as an emerging target of pharmacotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4188-3

21 January 2018

Differential regulation of the endocannabinoids anandamide and 2-arachidonylglycerol within the limbic forebrain by dopamine receptor activity

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4188-3

21 January 2018

Clinical trials of resveratrol

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4188-3

21 January 2018

Resveratrol: one molecule, many targets

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4188-3

21 January 2018

Altered CB receptor-signaling in prefrontal cortex from an animal model of depression is reversed by chronic fluoxetine.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4188-3

21 January 2018

Understanding the anti-kindling role and its mechanism of Resveratrol in Pentylenetetrazole induced-kindling in a rat model

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4188-3

21 January 2018

Neurotrophic signaling cascades in the pathophysiology and treatment of bipolar disorder

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4188-3

21 January 2018

Resveratrol as a therapeutic agent for neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4188-3

21 January 2018

Anticonvulsant tolerance to clonazepam in amygdala kindled rats: clonazepam concentrations and benzodiazepine receptor binding.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4188-3

21 January 2018

Intracellular signaling pathways pave roads to recovery for mood disorders

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4188-3

21 January 2018

The journey of resveratrol from yeast to human

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4188-3

21 January 2018

Resveratrol and clinical trials: the crossroad from in vitro studies to human evidence

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4188-3

21 January 2018

Resveratrol does not influence metabolic risk markers related to cardiovascular health in overweight and slightly obese subjects: a randomized, placebo-controlled crossover trial

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4188-3

21 January 2018

Complementary and alternative medicine in the treatment of anxiety and depression

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4188-3

21 January 2018

Differential effects of typical and atypical antipsychotics on nerve growth factor and choline acetyltransferase expression in the cortex and nucleus basalis of rats.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4188-3

21 January 2018

Endocannabinoid system and stress and anxiety responses.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4188-3

21 January 2018

Endocannabinoid system and synaptic plasticity: implications for emotional responses

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4188-3

21 January 2018

Antidepressant-like activity of resveratrol treatment in the forced swim test and tail suspension test in mice: the HPA axis, BDNF expression and phosphorylation of ERK.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4188-3

21 January 2018

The FGF receptor uses the endocannabinoid signaling system to couple to an axonal growth response

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4188-3

21 January 2018

Antidepressant-like effect of trans-resveratrol: Involvement of serotonin and noradrenaline system

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4188-3

21 January 2018

Alpha2-adrenoceptor blockade accelerates the neurogenic, neurotrophic, and behavioral effects of chronic antidepressant treatment.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4188-3

21 January 2018

Resveratrol supplementation does not improve metabolic function in nonobese women with normal glucose tolerance

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4188-3

21 January 2018

Antidepressant-like effect of trans-resveratrol in chronic stress model: behavioral and neurochemical evidences

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4188-3

21 January 2018

Resveratrol inhibits inflammatory responses via the mammalian target of rapamycin signaling pathway in cultured LPS-stimulated microglial cells

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4188-3

21 January 2018

Nerve growth factor facilitates cholinergic neurotransmission between nucleus basalis and the amygdala in rat: an electrophysiological analysis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26780936

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Favorable effects of berry consumption on platelet function, blood pressure, and HDL cholesterol

1 reference

https://pubmed.ncbi.nlm.nih.gov/26780936

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antidepressant-like effect of resveratrol: involvement of antioxidant effect and peripheral regulation on HPA axis

1 reference

https://pubmed.ncbi.nlm.nih.gov/26780936

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Role of the Endocannabinoids in Suppression of the Hypothalamic-pituitary-adrenal Axis Activity by Doxepin

1 reference

https://pubmed.ncbi.nlm.nih.gov/26780936

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Drug-drug interactions with the use of psychotropic medications. Interview by Diane M. Sloan.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26780936

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neuromodulatory functions of the endocannabinoid system

1 reference

https://pubmed.ncbi.nlm.nih.gov/26780936

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Resveratrol prevents age-related memory and mood dysfunction with increased hippocampal neurogenesis and microvasculature, and reduced glial activation

1 reference

https://pubmed.ncbi.nlm.nih.gov/26780936

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acute administration of amitriptyline and mianserin increases dopamine release in the rat nucleus accumbens: possible involvement of serotonin 2C receptors

1 reference

https://pubmed.ncbi.nlm.nih.gov/26780936

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cannabinoid CB1 Receptors Mediate the Gastroprotective Effect of Neurotensin

1 reference

https://pubmed.ncbi.nlm.nih.gov/26780936

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Resveratrol Does Not Benefit Patients With Nonalcoholic Fatty Liver Disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/26780936

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Liquid chromatographic-atmospheric pressure chemical ionization mass spectrometric determination of anandamide and its analogs in rat brain and peripheral tissues

1 reference

https://pubmed.ncbi.nlm.nih.gov/26780936

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nerve growth factor (NGF) augments cortical and hippocampal cholinergic functioning after p75NGF receptor-mediated deafferentation but impairs inhibitory avoidance and induces fear-related behaviors.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26780936

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nerve growth factor (NGF) content in adult rat brain tissues is several-fold higher than generally reported and is largely associated with sedimentable fractions

1 reference

https://pubmed.ncbi.nlm.nih.gov/26780936

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00213-015-4188-3

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/26780936

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/26780936

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47595268&oldid=2161218918"